Dongwha Pharm.Co.,Ltd (KRX:000020)
South Korea · Delayed Price · Currency is KRW 5,830.00
-100.00 (-1.69%)
At close: Apr 2, 2026
Dongwha Pharm.Co.,Ltd Market Cap
Dongwha Pharm.Co.,Ltd has a market cap or net worth of 161.6 billion as of April 2, 2026. Its market cap has decreased by -7.31% in one year.
Market Cap
161.60B
Enterprise Value
282.34B
Revenue
496.39B
Ranking
n/a
PE Ratio
18.63
Stock Price
5,830.00
Market Cap Chart
Since August 28, 1995, Dongwha Pharm.Co.,Ltd's market cap has increased from 72.32B to 161.60B, an increase of 123.43%. That is a compound annual growth rate of 2.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 161.60B | -6.72% |
| Dec 30, 2025 | 173.24B | -0.79% |
| Dec 30, 2024 | 174.62B | -38.57% |
| Dec 28, 2023 | 284.26B | 10.91% |
| Dec 29, 2022 | 256.31B | -36.58% |
| Dec 30, 2021 | 404.12B | -25.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ilyang Pharmaceutical Co.,Ltd | 200.94B |
| Kyongbo Pharmaceutical | 200.82B |
| AptaBio Therapeutics | 193.84B |
| Whan In Pharm | 192.60B |
| REYON Pharmaceutical | 184.14B |
| SAMSUNG PHARM. Co., LTD. | 178.36B |
| Daihan Pharmaceutical | 168.76B |
| Hana Pharm | 165.29B |